{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:15:02Z","timestamp":1773152102584,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004333","name":"La Jolla Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004333","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.mvr.2024.104709","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T17:35:09Z","timestamp":1719336909000},"page":"104709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Synthetic Angiotensin II ameliorates alterations of systemic hemodynamics, microcirculatory deterioration, and renal damage in septic rats"],"prefix":"10.1016","volume":"155","author":[{"given":"Bulent","family":"Ergin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Kapucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakhmir","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Ince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2024.104709_bb0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMra064398","article-title":"Normotensive ischemic acute renal failure","volume":"357","author":"Abuelo","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.21037\/atm-21-621","article-title":"Angiotensin II-mediated improvement of renal mitochondrial function via the AMPK\/PGC-1\u03b1\/NRF-2 pathway is superior to norepinephrine in a rat model of septic shock associated with acute renal injury","volume":"9","author":"An","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40635-015-0040-7","article-title":"Cytocam-IDF (incident dark field illumination) imaging for bedside monitoring of the microcirculation","volume":"3","author":"Aykut","year":"2015","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.mvr.2024.104709_bb0020","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/CCM.0000000000002441","article-title":"Clinical experience with IV angiotensin II administration: a systematic review of safety","volume":"45","author":"Busse","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0025","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/CCM.0b013e31816a023c","article-title":"Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury","volume":"36","author":"Casillas-Ramirez","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.mvr.2024.104709_bb0035","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1097\/CCM.0000000000000397","article-title":"Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis","volume":"42","author":"Corr\u00eaa","year":"2014","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0040","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/ndt\/gfu105","article-title":"The renal microcirculation in sepsis","volume":"30","author":"Ergin","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mvr.2024.104709_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000000573","article-title":"Fully balanced fluids do not improve microvascular oxygenation, acidosis and renal function in a rat model of endotoxemia","author":"Ergin","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.mvr.2024.104709_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40635-016-0106-1","article-title":"Effects of N-acetylcysteine (NAC) supplementation in resuscitation fluids on renal microcirculatory oxygenation, inflammation, and function in a rat model of endotoxemia","volume":"4","author":"Ergin","year":"2016","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.mvr.2024.104709_bb0060","article-title":"Hydroxyl Ethyl Starch (HES) preserves intrarenal microcirculatory perfusion shown by contrast-enhanced ultrasound (CEUS), and renal function in a severe hemodilution model in pigs","author":"Ergin","year":"2021","journal-title":"Shock"},{"key":"10.1016\/j.mvr.2024.104709_bb0065","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10877-023-00978-7","article-title":"Intra-renal microcirculatory alterations on non-traumatic hemorrhagic shock induced acute kidney injury in pigs","volume":"37","author":"Ergin","year":"2023","journal-title":"J. Clin. Monit. Comput."},{"key":"10.1016\/j.mvr.2024.104709_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1603017","article-title":"Initiation strategies for renal-replacement therapy in the intensive care unit","volume":"375","author":"Gaudry","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"122","key":"10.1016\/j.mvr.2024.104709_bb0075","first-page":"307","article-title":"A LED-based phosphorimeter for measurement of microcirculatory oxygen pressure","volume":"2017","author":"Guerci","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.mvr.2024.104709_bb0080","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/CCM.0b013e3181958d91","article-title":"Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models","volume":"37","author":"Hagiwara","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s42003-019-0473-8","article-title":"MicroTools enables automated quantification of capillary density and red blood cell velocity in handheld vital microscopy","volume":"2","author":"Hilty","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.mvr.2024.104709_bb0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0095","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/CCM.0b013e31828a6688","article-title":"Angiotensin-(1\u20137) protects from experimental acute lung injury","volume":"41","author":"Klein","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0001-5172.2004.00283.x","article-title":"The angiotensin II receptor blocker candesartan improves survival and mesenteric perfusion in an acute porcine endotoxin model","volume":"48","author":"Laesser","year":"2004","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.mvr.2024.104709_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1620\/tjem.238.17","article-title":"Renin-angiotensin-aldosterone system blockade in critically ill patients is associated with increased risk for acute kidney injury","volume":"238","author":"Lim","year":"2016","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000003209","article-title":"Dynamic contrast-enhanced ultrasound identifies microcirculatory alterations in sepsis-induced acute kidney injury","author":"Lima","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0115","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00134-012-2487-2","article-title":"Renal bioenergetics during early Gram-negative mammalian sepsis and angiotensin II infusion","volume":"38","author":"May","year":"2012","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0120","doi-asserted-by":"crossref","first-page":"F496","DOI":"10.1152\/ajprenal.00121.2014","article-title":"Alternative pathways for angiotensin II production as an important determinant of kidney damage in endotoxemia","volume":"311","author":"Rosa","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.mvr.2024.104709_bb0125","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.mvr.2024.104709_bb0135","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00000658-200004000-00017","article-title":"Angiotensin II inhibitor DuP753 attenuates burn- and endotoxin-induced gut ischemia, lipid peroxidation, mucosal permeability, and bacterial translocation","volume":"231","author":"Tadros","year":"2000","journal-title":"Ann. Surg."},{"key":"10.1016\/j.mvr.2024.104709_bb0140","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/CCM.0b013e3181c03009","article-title":"Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets","volume":"38","author":"Treml","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mvr.2024.104709_bb0145","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Acute renal failure in critically ill patients: a multinational, multicenter study","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.mvr.2024.104709_bb0150","doi-asserted-by":"crossref","first-page":"R190","DOI":"10.1186\/cc8185","article-title":"Angiotensin II in experimental hyperdynamic sepsis","volume":"13","author":"Wan","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.mvr.2024.104709_bb0155","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/0886022X.2022.2095286","article-title":"Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study","volume":"44","author":"Wang","year":"2022","journal-title":"Ren. Fail."},{"key":"10.1016\/j.mvr.2024.104709_bb0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit. Care"},{"key":"10.1016\/j.mvr.2024.104709_bb0165","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13054-016-1581-1","article-title":"Blood transfusion improves renal oxygenation and renal function in sepsis-induced acute kidney injury in rats","volume":"20","author":"Zafrani","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.mvr.2024.104709_bb0170","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2016.5828","article-title":"Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial","volume":"315","author":"Zarbock","year":"2016","journal-title":"JAMA"}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002628622400058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002628622400058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T05:51:34Z","timestamp":1722750694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002628622400058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"alternative-id":["S002628622400058X"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2024.104709","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic Angiotensin II ameliorates alterations of systemic hemodynamics, microcirculatory deterioration, and renal damage in septic rats","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2024.104709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104709"}}